SCHEMBL16068005

SCHEMBL16068005

c1ccc(-c2cccc(-c3c4ccccc4c(-c4ccc5c(c4)oc4c6ccccc6ccc54)c4ccccc34)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 15/20 0.46
CYP1B1 Q16678 15/20 0.46
CYP1A2 P05177 14/20 0.46
PRKDC P78527 3/20 0.46
ABCG2 Q9UNQ0 3/20 0.46
ABCC1 P33527 2/20 0.46
KDM4E B2RXH2 1/20 0.46
PDE5A O76074 1/20 0.46
ALDH1A1 P00352 1/20 0.46
TP53 P04637 1/20 0.46
ABCB1 P08183 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
MAPT P10636 1/20 0.46
CYP19A1 P11511 1/20 0.46
CYP2C9 P11712 1/20 0.46
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.46
CYP2B6 P20813 1/20 0.46
TACR2 P21452 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16067565 0.97 CYP1A1 (0.46) CYP1A1CYP1B1CYP1A2PRKDCABCG2
SCHEMBL27012203 0.94 CYP1A1 (0.46) CYP1A1CYP1B1CYP1A2PRKDCABCG2
SCHEMBL17943890 0.94 CYP1A1 (0.47) CYP1A1CYP1B1CYP1A2PRKDCABCG2
SCHEMBL17944661 0.94 CYP1A1 (0.48) CYP1A1CYP1B1CYP1A2PRKDCABCG2
SCHEMBL27012117 0.94 CYP1A1 (0.48) CYP1A1CYP1B1CYP1A2PRKDCABCG2
SCHEMBL16068008 0.94 CYP1A1 (0.48) CYP1A1CYP1B1CYP1A2PRKDCABCG2
SCHEMBL16068009 0.93 CYP1A1 (0.49) CYP1A1CYP1B1CYP1A2PRKDCABCG2
SCHEMBL20127531 0.93 CYP1A1 (0.42) CYP1A1CYP1B1CYP1A2PRKDCABCG2
SCHEMBL16067776 0.93 CYP1A1 (0.49) CYP1A1CYP1B1CYP1A2PRKDCABCG2
SCHEMBL17943929 0.93 CYP1A1 (0.47) CYP1A1CYP1B1CYP1A2PRKDCABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240023436-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-01-18 US disclosed
US-11839153-B2 Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO.,LTD. (JP) 2023-12-05 US disclosed
US-11839153-B2 Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO.,LTD. (JP) 2023-12-05 US disclosed
US-20230329025-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-10-12 US disclosed
US-20230329025-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-10-12 US disclosed
WO-2023190597-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE 出光興産株式会社 2023-10-05 WO disclosed
EP-4242196-A1 METHOD FOR PREPARING DEUTERATED ANTHRACENE COMPOUND, REACTION COMPOSITION, DEUTERATED ANTHRACENE COMPOUND AND COMPOSITION Lg Chem, Ltd. (KR) 2023-09-13 EP disclosed
US-20230137925-A1 HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND IDEMITSU KOSAN CO.,LTD (JP) 2023-05-04 US disclosed
US-20230137925-A1 HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND IDEMITSU KOSAN CO.,LTD (JP) 2023-05-04 US disclosed
US-20230127629-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-04-27 US disclosed
US-9954187-B2 Compound, organic electroluminescence device and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2018-04-24 US disclosed
US-9954187-B2 Compound, organic electroluminescence device and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2018-04-24 US disclosed
US-9947879-B2 Anthracene derivative and organic electroluminescence element using same IDEMITSU KOSAN CO., LTD. (JP) 2018-04-17 US disclosed
US-9947879-B2 Anthracene derivative and organic electroluminescence element using same IDEMITSU KOSAN CO., LTD. (JP) 2018-04-17 US disclosed
US-20170324045-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-11-09 US disclosed
US-20170324045-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-11-09 US disclosed
US-20150325800-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2015-11-12 US disclosed
US-20150325800-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2015-11-12 US disclosed
EP-2924029-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME Idemitsu Kosan Co., Ltd (JP) 2015-09-30 EP disclosed
WO-2014141725-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME 出光興産株式会社 (JP) 2014-09-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11839153-B2 Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device RER1, RPS19, RPL19 CYP1A1 1954/4885CYP1B1 1677/4885CYP1A2 3468/4885
US-20240023436-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE EED, EML4, ESR1 CYP1A1 2486/4885CYP1B1 3756/4885CYP1A2 2064/4885
US-20150325800-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME ANXA1, ANXA11, L1CAM CYP1A1 61/4885CYP1B1 276/4885CYP1A2 252/4885
US-20170324045-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE LEF1, L1CAM, EMC1 CYP1A1 251/4885CYP1B1 137/4885CYP1A2 692/4885
US-20230137925-A1 HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND DDT, DDC, ODC1 CYP1A1 253/4885CYP1B1 549/4885CYP1A2 266/4885
US-20230127629-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, EPCAM, TMEM109 CYP1A1 578/4885CYP1B1 666/4885CYP1A2 671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.